Literature DB >> 8441264

A suitable model for experimental liver metastasis of human colon cancer xenografts using mice with severe combined immunodeficiency.

T Furukawa1, T Kubota, M Watanabe, H Nishibori, T H Kuo, Y Saikawa, S Kase, H Tanino, T Teramoto, K Ishibiki.   

Abstract

Studies on liver metastasis of human colon cancer are limited because of a lack of suitable animal models. In this study, the usefulness of mice with severe combined immunodeficiency (SCID), which congenitally lack functional T and B lymphocytes, was evaluated in comparison with currently available nude mice. Three human colon cancer xenografts transplantable into nude mice were disaggregated enzymatically to obtain tumor cell suspensions, and implanted intrasplenically into SCID and nude mice. The incidence of splenic tumorigenesis and of liver metastases were significantly greater in SCID mice for all xenografts, in comparison with nude mice. In total, 33 of 36 SCID mice and 17 of 43 nude mice developed liver metastases. On the basis of this result, we conclude that SCID mice would be a more suitable model than nude mice for studying liver metastasis of human colon cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8441264     DOI: 10.1002/jso.2930520117

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.

Authors:  Atsushi Kodama; Hiroki Sakai; Satoko Matsuura; Mami Murakami; Atsuko Murai; Takashi Mori; Kouji Maruo; Tohru Kimura; Toshiaki Masegi; Tokuma Yanai
Journal:  BMC Cancer       Date:  2009-10-14       Impact factor: 4.430

2.  Establishment and Validation of an Orthotopic Metastatic Mouse Model of Colorectal Cancer.

Authors:  Ashwani Rajput; Ekta Agarwal; Premila Leiphrakpam; Michael G Brattain; Sanjib Chowdhury
Journal:  ISRN Hepatol       Date:  2013-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.